At a recent event organized by that consortium, the New Jersey Alliance for Clinical and Translational Science(NJACTS), leaders from academia, healthcare, government and the pharmaceutical industry discussed the future of scientific and clinical trial innovation in the state. These new innovations will result from a $33-million grant from the National Institutes of Health (NIH). To read the full story.
Recent Posts
- NJACTS Community Engagement Core Available Services
- Low Medicaid rates force N.J. pediatrician to retire after 50 years, she says.
- New NJACTS Publication
- Scientists Find Why Ozempic Changes the Types of Food People Eat.
- Rutgers Physician Assistant Studies is Third in U.S. News and World Report’s Graduate School Rankings.
Categories
- Community (2,263)
- Covid (986)
- CTO Events (6)
- News (2,883)
- Pilots (21)